top of page

Arstat Pharmaceuticals

Advancing Transformational Products for Tens of Millions of Women

Our Portfolio

One of the Best Portfolios in Women’s Health

Fifteen US and EU patents, two Phase III-ready products,
two likely blockbusters 

Happy Artist
Happy Woman Posing
Natural Beauty
Woman & Doctor


  The first and only 

contraceptive endorsed by the FDA for exclusive testing and labeling for women with overweight and obesity


(20 million US contraceptive users)

  Addressing a high public health priority in the post-Roe world



medicated vaginal ring for uterine fibroids and endometriosis


(>15 million US women)

   Designed to drastically reduce the need for radical surgeries



single non-hormonal therapy for painful, heavy menstrual periods


(>25 million US women)

  A potential treatment of choice for a common menstrual disorder 


Develop Safe and Effective Solutions for Highly Prevalent, Under-treated Reproductive Conditions and Disorders

Opportunity Details

Want to learn the Arstat basics?

Click the PDF below.



Ready to review this opportunity? Click the PDF below.

Contact Us

Contact Us

We are reaching out to partners, executives (including a CEO and a Chairman of the Board), and advisors

bottom of page